Westrick Thomas J.

SEC source: 0001628280-25-010709 · wk-form4_1741221969.xml · derivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,096

Underlying: Common Stock, par value $0.01 per share · 9,096 shares

Expires 2035-03-03

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010709 · wk-form4_1741221969.xml · nonDerivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,501

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-009992 · wk-form4_1741127446.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,269

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-25-010709 · wk-form4_1741221969.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,320

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-25-003736 · wk-form4_1738704177.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,142

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-24-035773 · wk-form4_1723069129.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,509

F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $80.78 to $80.84, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · derivative · entry 6

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,435

Underlying: Common Stock, par value $0.01 per share · 8,435 shares

Expires 2034-03-01

F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 5

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,259

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.

F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 4

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,294

F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023.

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,415

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,584

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,869

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · nonDerivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,557

F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · derivative · entry 4

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,188

Underlying: Common Stock, par value $0.01 per share · 10,188 shares

Expires 2033-03-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.

SEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · nonDerivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,122

F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,161

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-23-042947 · wk-form4_1703890882.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,064

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

SEC source: 0001628280-23-002255 · wf-form4_167546515533806.xml · derivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,244

Underlying: Common Stock, par value $0.01 per share · 17,244 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002255 · wf-form4_167546515533806.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,509

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 1,964 newly awarded restricted stock units and 12,545 previously reported restricted stock units.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 12

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,464

Underlying: Common stock, par value $0.01 per share · 5,464 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F6 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 11

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,568

Underlying: Common stock, par value $0.01 per share · 5,568 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F5 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F5 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F5 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 10

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,513

Underlying: Common stock, par value $0.01 per share · 1,513 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F4 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F4 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F4 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 9

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,465

Underlying: Common stock, par value $0.01 per share · 13,465 shares

Expires 2030-03-02

F2 · price: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 8

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,229

Underlying: Common stock, par value $0.01 per share · 3,229 shares

Expires 2029-04-11

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 7

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,725

Underlying: Common stock, par value $0.01 per share · 23,725 shares

Expires 2028-12-21

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 6

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,312

Underlying: Common stock, par value $0.01 per share · 9,312 shares

Expires 2028-03-19

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 5

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,446

Underlying: Common stock, par value $0.01 per share · 17,446 shares

Expires 2027-11-17

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 4

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,804

Underlying: Common stock, par value $0.01 per share · 7,804 shares

Expires 2026-09-30

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,773

Underlying: Common stock, par value $0.01 per share · 13,773 shares

Expires 2025-09-11

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,773

Underlying: Common stock, par value $0.01 per share · 13,773 shares

Expires 2024-09-05

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001104 · doc4.xml · derivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,733

Underlying: Common stock, par value $0.01 per share · 9,733 shares

Expires 2023-09-13

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% is fully exercisable immediately.